AMGN
Amgen Inc
Price:  
298.50 
USD
Volume:  
1,732,541.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Amgen EV/EBITDA

-32.7%
Upside

As of 2024-06-14, the EV/EBITDA ratio of Amgen Inc (AMGN) is 18.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Amgen's latest enterprise value is 214,436.36 mil USD. Amgen's TTM EBITDA according to its financial statements is 11,776.00 mil USD. Dividing these 2 quantities gives us the above Amgen EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.6x - 15.0x 12.6x
Forward P/E multiples 11.1x - 17.4x 14.3x
Fair Price 132.33 - 298.56 200.97
Upside -55.7% - 0.0% -32.7%
298.50 USD
Stock Price
200.97 USD
Fair Price

Amgen EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-13 18.21
2024-06-12 18.33
2024-06-11 18.31
2024-06-10 18.49
2024-06-07 18.51
2024-06-06 18.54
2024-06-05 18.61
2024-06-04 18.61
2024-06-03 18.62
2024-05-31 18.54
2024-05-30 18.32
2024-05-29 18.11
2024-05-28 18.29
2024-05-24 18.54
2024-05-23 18.57
2024-05-22 18.71
2024-05-21 18.95
2024-05-20 18.94
2024-05-17 18.85
2024-05-16 18.95
2024-05-15 19.15
2024-05-14 18.80
2024-05-13 18.66
2024-05-10 18.74
2024-05-09 18.86
2024-05-08 18.61
2024-05-07 18.29
2024-05-06 18.25
2024-05-03 18.79
2024-05-02 17.29
2024-05-01 17.25
2024-04-30 17.09
2024-04-29 17.20
2024-04-26 16.91
2024-04-25 16.88
2024-04-24 17.05
2024-04-23 17.07
2024-04-22 17.00
2024-04-19 16.86
2024-04-18 16.58
2024-04-17 16.64
2024-04-16 16.71
2024-04-15 16.71
2024-04-12 16.79
2024-04-11 16.91
2024-04-10 16.75
2024-04-09 16.93
2024-04-08 16.87
2024-04-05 16.91
2024-04-04 16.82